These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22725674)

  • 1. Male-to-female gender ratio in fetuses with increased nuchal translucency.
    Daouk ME; Brustman L; Langer O; Lysikiewicz A
    J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2613-5. PubMed ID: 22725674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Male gender as a favorable prognostic factor in pregnancies with enlarged nuchal translucency.
    Timmerman E; Pajkrt E; Bilardo CM
    Ultrasound Obstet Gynecol; 2009 Oct; 34(4):373-8. PubMed ID: 19618399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prospective cohort study of fetal nuchal translucency in first-trimester and pregnancy outcome].
    Tang HR; Zhang Y; Ru T; Li J; Yang L; Xu Y; Duan HL; Wang Y; Wang Y; Hu YL; Zhang Y; Zheng MM
    Zhonghua Fu Chan Ke Za Zhi; 2020 Feb; 55(2):94-99. PubMed ID: 32146737
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased nuchal translucency and normal karyotype: perinatal and pediatric outcomes at 2 years of age.
    Mula R; Goncé A; Bennásar M; Arigita M; Meler E; Nadal A; Sánchez A; Botet F; Borrell A
    Ultrasound Obstet Gynecol; 2012 Jan; 39(1):34-41. PubMed ID: 21837766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuchal translucency thickness in euploid fetuses: is two millimeters too risky?
    Fink M; Sheiner E; Sheizaf B; Hershkovitz R; Bashiri A; Mazor M; Wiznitzer A
    Am J Perinatol; 2009 Apr; 26(4):303-7. PubMed ID: 19031359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal relationship between increased nuchal translucency and enlarged jugular lymphatic sac.
    Bekker MN; Twisk JW; Bartelings MM; Gittenberger-de Groot AC; van Vugt JM
    Obstet Gynecol; 2006 Oct; 108(4):846-53. PubMed ID: 17012445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of detailed first trimester ultrasound examination in abnormal fetal nuchal translucency.
    Bronshtein M; Zimmer EZ; Blazer S
    Prenat Diagn; 2008 Nov; 28(11):1037-41. PubMed ID: 18925580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. By how much does increased nuchal translucency increase the risk of adverse pregnancy outcome in chromosomally normal fetuses? A study of 16,260 fetuses derived from an unselected pregnant population.
    Westin M; Saltvedt S; Almström H; Grunewald C; Valentin L
    Ultrasound Obstet Gynecol; 2007 Feb; 29(2):150-8. PubMed ID: 17211897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death.
    Spencer K; Cowans NJ; Avgidou K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Oct; 28(5):637-43. PubMed ID: 16952214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic value of a detailed first trimester anomaly scan in fetuses with increased nuchal translucency thickness.
    Tekesin I
    J Perinat Med; 2019 Feb; 47(2):241-246. PubMed ID: 30218607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses.
    Spencer K; Cowans NJ; Avgidou K; Molina F; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Jan; 31(1):15-9. PubMed ID: 17999381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
    Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of the contents of exomphalos and nuchal translucency at 11-14 weeks on the likelihood of associated chromosomal abnormality.
    Iacovella C; Contro E; Ghi T; Pilu G; Papageorghiou A; Thilaganathan B; Bhide A
    Prenat Diagn; 2012 Nov; 32(11):1066-70. PubMed ID: 22961234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse pregnancy outcome in fetuses with early increased nuchal translucency: prospective cohort study.
    Bet BB; Lugthart MA; Linskens IH; van Maarle MC; van Leeuwen E; Pajkrt E
    Ultrasound Obstet Gynecol; 2024 Aug; 64(2):164-172. PubMed ID: 38411313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The added value of detailed early anomaly scan in fetuses with increased nuchal translucency.
    Zalel Y; Zemet R; Kivilevitch Z
    Prenat Diagn; 2017 Mar; 37(3):235-243. PubMed ID: 28010037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Karyotype and outcome of fetuses diagnosed with cystic hygroma in the first trimester in relation to nuchal translucency thickness.
    Kharrat R; Yamamoto M; Roume J; Couderc S; Vialard F; Hillion Y; Ville Y
    Prenat Diagn; 2006 Apr; 26(4):369-72. PubMed ID: 16566042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there any relationship between adverse pregnancy outcome and first trimester nuchal translucency measurements in normal karyotype fetuses?
    Uysal F; Coşar E; Yücesoy K; Gencer M; Cevizci S; Güngör A; Hacıvelioğlu S; Uysal A
    J Matern Fetal Neonatal Med; 2015 Mar; 28(5):531-4. PubMed ID: 24824104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy outcome of euploid fetuses with increased nuchal translucency: how bad is the news?
    Maymon R; Weinraub Z; Herman A
    J Perinat Med; 2005; 33(3):191-8. PubMed ID: 15914340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
    Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
    Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for aneuploidies by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-13+6 gestational weeks.
    Karadzov-Orlić N; Egić A; Filimonović D; Marinković M; Damnjanović-Pazin B; Milovanović Z; Joksić I; Branković S; Lukić R; Mandić V; Cerović N; Mojović D; Plamenac S; Stanković M; Maglić D; Mikovć Z
    Srp Arh Celok Lek; 2012; 140(9-10):606-11. PubMed ID: 23289277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.